A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of ...

Medicus Pharma Ltd. (Nasdaq: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets. The Company is ...

A powerful new treatment could soon help men whose prostate cancer returns after surgery or radiation. A large study shows ...

Health experts from the University of Exeter have played a key role in the shift, after conducting an economic evaluation of ...

The lifetime risk of Malaysian men developing cancer has increased from one in ten to one in eight, with colorectal, lung and ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

This is an opinion column. Sometimes I get mixed up. That’s not unusual. Not at this age. You’d think, though, that I’d be crystal clear about my prostate cancer treatment. About the active ...

Oct. 21, 2025 – A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to unprecedented results of a drug treatment trial in men whose ...

WASHINGTON(AP) — Former President Joe Biden on Monday completed a round of radiation therapy treatment for the aggressive form of prostate cancer he was diagnosed with after leaving office, a ...